Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001104659-15-070633

10% owner acquired 749,055 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Hadley Harbor Master Investors (Cayman) L.P. · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2015-10-14 Conversion : show line 1 in the form +749,055 749,055 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-10-14 Conversion : show line 2 in the form Series D Convertible Preferred Stock −749,055 0 D
Loading xslF345X03/a4.xml…